[273 Pages Report] The global Plant Derived Proteins Market is estimated to reach US$ 105 Mn by the end of 2022. Growing research and development activities for development of more effective drugs and biologic, especially across countries such as India, China, the U.S., and the U.K. is expected to bolster the growth in the market.
| Attribute | Details |
|---|---|
| Plant Derived Proteins Market Estimated Size in 2022 | US$ 105 Million |
| Plant Derived Proteins Market Projected Size in 2029 | US$ 184.3 Million |
| Plant Derived Proteins Market Historical CAGR (2014-2021) | 7.6% |
| Plant Derived Proteins Market Value-based CAGR (2022-2029) | 8.4% |
An exhaustive survey by Future Market Insights (FMI) reveals that the sales in the global plant derived proteins market is projected to exceed US$ 184.3 Mn, rising at a remarkable CAGR of 8.4% over the forecast period 2022-2029.
Based on plant type, the carrot segment is anticipated to exhibit the fastest growth in the market, accounting for more than 46.2% of the plant derived proteins sales by 2022. The plant derived proteins are expected to hold nearly 0.2% of the market share in the global animal and plant based protein market through 2029.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 8.89% |
| H1, 2022 Projected | 8.36% |
| H1, 2022 Outlook | 7.86% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 50 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 102 ↓ |
According to Future Market Insights analysis, the global plant derived proteins market expects to drop by 102 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 50 BPS. The market is subject to regulatory dynamics, pricing fluctuations, and licensing of biologics.
The dip in the BPS values for the market is associated with the emergence of the “free-form” anthology in specialty foods which encloses a gluten and soy-free diet. With the establishment of increased customer choice for gluten and soy-free food products, the market for plant derived products observed a decline in the BPS values.
Conversely, plant derived scaffold proteins for research purposes support cell adhesion and proliferation for regenerative medicine and drug screening by forming critical biomatrices. This has supported promising clinical outlooks, and will pose a positive impact upon the market growth.
The demand in the global plant derived proteins market grew at a CAGR of 7.6% over the past assessment period 2014-2021. Plant derived proteins are estimated to create an absolute dollar opportunity of US$ 105 Mn by the end of 2022.
Plant derived proteins are biologics sourced from tobacco leaves, rice seeds, carrots, and others by molecular farming or cell-culture procedures. These proteins are natural and environmentally sustainable and have significant potential in comparison to other biologics such as microbial and mammalian cells. For instance, the plant derived experimental antibody named ZMapp was reported to be more effective against the Ebola Virus than others.
Hence, advancements in plant expression vectors, glycoengineering, and downstream processing have resulted in increasing use of plants as a superior alternative for biologics production. Driven by this, the sales in the global plant derived proteins are estimated to surpass US$ 184.3 Mn by the end of 2029.
Rising prevalence of diseases such as diabetes, hepatitis, lymphoma, and Gaucher disease among others across the world has created strong demand for advanced therapeutics. This significant surge in demand for biologics and drugs cannot be met by current production platforms such as microbial and mammalian cells due to their higher cost and limited scalability.
Hence, numerous biopharmaceutical companies are shifting their focus on using animal-free substitutes such as plants owing to their benefit such as eukaryotic protein modification, high scalability, low cost. This is estimated to accelerate the sales of plant derived proteins in the market.
In addition to this, increasing usage of plant derived proteins as raw materials for therapeutic drug production and surging demand for replacement proteins such as insulin and albumin is expected to assist the market to expand at a CAGR of 8.4% over the forecast period 2022-2029.
Implementation of stringent guidelines and standards for the production of plant derived proteins by regulatory bodies such as European Medicines Agency (EMA) and Food and Drug Administration (FDA) is hampering the sales in the market.
Also, implementation of ban on the plantation of tobacco in certain countries across Europe, increasing inclination towards biosimilar drugs, and rising incidence of allergic reactions to the drugs produced from genetically engineered plants are factors restraining the growth in the plant derived proteins market.
Principal Consultant
“Growing Emphasis on Launching Novel Therapeutics to Bolster Plant Derived Proteins Sales”
Future Market Insights states that the U.S. is projected to register the fastest growth in the North America plant derived proteins market over the assessment period.
With increasing demand for novel plant derived proteins and other biologics-based drugs, leading players in the country are increasingly focusing on developing novel therapeutics and vaccines. For instance, iBio, Inc., an American biologics manufacturing company, announced using its advanced FastPharming technologies to develop three novel plant-based biologics, IBIO-100, IBIO-200, and IBIO-201 in October 2020.
A slew of such developments and product launches is estimated to bolster the sales of plant derived proteins in the U.S. market.
“Increasing Burden of Diabetes to Fuel the Demand for Plant Derived Recombinant Proteins”
As per FMI, India, home to a large number of biotechnology and pharmaceutical companies, is estimated to emerge as the most lucrative plant derived proteins market in South Asia between 2022 and 2029.
The incidence of lifestyle diseases such as diabetes is rapidly increasing owing to the growing fast-paced lifestyle and changing eating habits in India. For instance, according to the International Diabetes Federation, around 74.19 million cases of diabetes between ages 20 to 79 were reported across India, exhibiting a 9.6% rate of incidence in 2021.
As plant derived recombinant proteins such as insulin are extensively being used by diabetic patients to maintain their insulin levels, rising burden of diabetes is expected to elevate the demand for plant derived proteins in India market.
“Rising Demand for Cosmetic Products to Bolster the Plant Derived Proteins Sales”
The U.K. is anticipated to register robust growth in the plant derived proteins market in Europe during the forecast period 2022-2029, reveals FMI.
Plant derived proteins are gaining immense popularity across the cosmetic industry, owing to their natural, better results, and environmentally-sustainable attributes. On account of this, leading industry players are shifting the preference towards using plant derived proteins from microbial and mammalian cells for the formulation of face creams, serums, and others cosmetic products.
Hence, rapidly increasing demand for cosmetic products on the back of rising emphasis on enhancing facial aesthetics among the population in the U.K. is projected to bolster the sales of plant derived proteins in the market.
“Growing Usage in Breast Cancer Treatment Drugs to Accelerate Plant Derived Therapeutic Proteins Demand”
The tobacco segment is estimated to register robust growth, accounting for nearly 39.6% of the plant derived proteins sales through 2022.
Tobacco plant is considered as the ideal host for plant-based engineered proteins owing to its high yield production, rapid plant growth, and ability to produce large amounts of antibodies within 6 to 7 days. In addition to this, increasing use of tobacco derived proteins in breast cancer treatment drugs is favoring sales of plant derives therapeutic proteins in the segment.
“Rising Adoption of Novel Cell Culture Platforms to Favor the Plant Derived Proteins Market Growth”
On the basis of platform, the global plant derived proteins market is segmented into in-vitro cell culture systems, whole plants, and others. FMI estimates that the in-vitro cell culture systems will account for a significant share in the market over the forecast period. Increasing adoption of novel cell culture platforms such as in-vitro cell culture by biopharmaceutical companies for novel drug production is driving the growth in the segment.
In terms of application, the regenerative medicine-therapeutic agents segment is projected to exhibit rapid growth in the global market through 2029. Growing usage of plant derived proteins as therapeutic agents across the cosmetics industry is the primary factor augmenting sales across the segment.
“Therapeutic Proteins Segment to Account for the Maximum Plant Derived Therapeutic Proteins Sales”
Therapeutic proteins demand is likely to grow at a rapid pace, accounting for more than 70% of the plant derived proteins sales from 2022 to 2029 in terms of protein.
Demand for plant derived therapeutics proteins such as monoclonal antibodies and vaccines is rapidly increasing on the back of their efficiency in the treatment of diseases. Hence, they are extensively being used for the production of biologics and drugs for the treatment of diseases such as anemia, hepatitis, cancer, hemophilia, and others, which is in turn, facilitating the growth in the segment.
“Rising Novel Drug Development Activities to Spur Sales of Plant Derived Proteins”
Among end users, biopharmaceutical companies are projected to continue leading the plant derived proteins market, accounting for over 50% of the demand share by the end of assessment period.
Increasing government support in research and development (R&D) activities for the production of more effective therapeutics drugs and shifting preference on using plant-based biologics owing to their high scalability and low cost are factor augmenting the sales across the segment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key players in the plant derived proteins market are focusing in adoption expansion strategies such as new product launch and product approval to gain competitive edge. Some of the other companies are aiming at collaboration, merger, and acquisition with other players to expand their market share. For instance,
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2029 |
| Historical Data Available for | 2014 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East & Africa |
| Key Countries Covered | USA, Canada, Germany, UK, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa |
| Key Segments Covered | Plant, Protein, Platform, Application, End User, and Region |
| Key Companies Profiled | Amgen Inc; Abbott Laboratories; AstraZeneca; Merck KGaA; Baxter International; Boehringer Ingelheim; Chugai Pharmaceutical; Diasome Pharmaceuticals; Eli Lilly & Company; Protalix Biotherapeutic; F. Hoffmann-La Roche; Generex Biotechnology; GeneScience Pharmaceuticals; Group Biogen Idec Inc; Hualan Biological Engineering; Johnson & Johnson; Kyowa Hakko Kirin; Novo Nordisk |
| Report Coverage | Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
By Plant:
By Protein:
By Platform:
By Application:
By End User:
By Region:
The plant derived proteins market is expected to surpass a valuation of US$ 105 Mn in 2022.
The global plant derived proteins market grew at a 7.6% CAGR over the past assessment period 2014-2021.
The plant derived proteins market is expected to register remarkable growth, expanding at 8.4% CAGR between 2022 and 2029.
North America currently leads the global plant derived proteins market, accounting maximum sales through 2029.
South Asia plant derived proteins market will hold a significant share over the assessment period 2022-2029.
In terms of plant type, the carrot segment is expected to dominate the global plant derived proteins market, accounting for over 46.2% of the revenue share through 2029.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition 2.3. Inclusion & Exclusion/Scope/Limitations 3. Key Market Trends 3.1. Key Trends Impacting The Market 3.2. Advancement & Key Development on Market 3.3. Business Level Trends and Market Developments 4. Key Success Factors 4.1. Key Strategies & Developments adopted by the Industry Incumbents 4.2. Product Adoption Rate/Usage Analysis, By Region 4.3. Vs. Application Matrix 4.4. Promotional Strategies, by Key Manufacturers 5. Global Market - Pricing Analysis 5.1. Key Regulations 5.2. Regional Raw Material Prices Analysis 5.3. End Product Prices Vs Raw material Prices 5.4. Regional Pricing Analysis, By End Product 5.5. Global Average Pricing Analysis Benchmark 6. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022–2029 6.1. Historical Market Value (US$ Mn) Analysis, 2014-2021 6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Market Background 7.1. Macro-Economic Factors 7.2. Global Healthcare Market Outlook & Size, 2021 7.3. Global Medical Device Market Outlook & Size, 2021 7.4. Parent Market Outlook & Size, 2021 7.5. Forecast Factors - Relevance & Impact 7.5.1. Key Player Annual Growth Rate 7.5.2. Product Cost 7.5.3. Product Availability 7.5.4. Production Demand 7.5.5. Key Market Consolidation Activities 7.6. Value Chain 7.7. Supply-Demand Scenario 7.7.1. Production vs. Consumption Outlook 7.7.2. Region-wise Demand 7.7.3. Potential Growth 7.7.4. Market Size, among others 7.8. Market Dynamics 7.8.1. Drivers 7.8.2. Restraints 7.8.3. Opportunity Analysis 8. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Plant Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Plant Type, 2014 - 2021 8.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Plant Type, 2022 - 2029 8.3.1. Tobacco 8.3.2. Carrot 8.3.3. Rice 8.3.4. Tomato 8.3.5. Maize Plant 8.3.6. Soybean 8.3.7. Safflower 8.3.8. Lettuce 8.3.9. Barley 8.3.10. Others 8.3.11. Others 8.4. Market Attractiveness Analysis By Plant Type 9. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Protein Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Protein Type, 2014 - 2021 9.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Protein Type, 2022 - 2029 9.3.1. Protein Biopolymers 9.3.1.1. Spider Silk Proteins 9.3.1.2. Elastin Like Polypeptides (ELPs) 9.3.1.3. Collagens 9.3.1.4. Others 9.3.2. Industrial Proteins & Enzymes 9.3.2.1. Hydrolases 9.3.2.2. Glycosidases 9.3.2.3. Proteases 9.3.2.4. Others 9.3.3. Therapeutic Proteins 9.3.3.1. Blood Proteins 9.3.3.2. Vaccine Antigens, 9.3.3.3. Monoclonal antibodies (mAbs) 9.3.3.4. Cytokines, 9.3.3.5. Growth factors 9.3.3.6. Growth Hormones 9.3.3.7. Others 9.3.4. Cell Culture Functional Proteins 9.3.4.1. Albumin 9.3.4.2. Transferrin 9.3.4.3. Fibronectin 9.3.4.4. Aprotinin 9.3.4.5. Fetuin 9.3.4.6. Others 9.4. Market Attractiveness Analysis By Protein Type 10. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Platform Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Platform Type, 2014 - 2021 10.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Platform Type, 2022 - 2029 10.3.1. In-vitro Culture System 10.3.1.1. Plant cell suspensions 10.3.1.2. Hairy Roots 10.3.1.3. Moss 10.3.2. Aquatic plants 10.3.2.1. Duckweed 10.3.2.2. Microalgae 10.3.3. Whole plants 10.3.3.1. Stable Transgenic Plants 10.3.3.2. Transient Plants Polyclonal 10.4. Market Attractiveness Analysis By Platform Type 11. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Application, 2014 - 2021 11.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Application, 2022 - 2029 11.3.1. Regenerative Medicine-Therapeutic Agents 11.3.1.1. Primary Cell Based Therapeutic 11.3.1.2. Stem Cell & Progenitor Cell-based Therapeutics 11.3.2. Regenerative Medicine-Functional Material 11.3.3. Cell Culture Application 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2014-2021 and Forecast 2022-2029, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By End User, 2014 - 2021 12.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2021 - 2021 12.3.1. Biopharmaceutical Companies 12.3.1.1. In-vitro Culture System 12.3.1.2. Aquatic plants 12.3.1.3. Whole plants 12.3.2. Academic & Research Institutes 12.3.2.1. In-vitro Culture System 12.3.2.2. Aquatic plants 12.3.2.3. Whole plants 12.3.3. Contract Research Organization (CROs) 12.3.3.1. In-vitro Culture System 12.3.3.2. Aquatic plants 12.3.3.3. Whole plants 12.3.4. Contract Manufacturing Organization (CMOs) 12.3.4.1. In-vitro Culture System 12.3.4.2. Aquatic plants 12.3.4.3. Whole plants 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Region, 2014 - 2021 13.3. Current Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2021 - 2021 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. Middle East and Africa (MEA) 13.3.5. East Asia 13.3.6. South Asia 13.3.7. Oceania 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2014-2021 and Forecast 2022-2029 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021 14.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029 14.4.1. By Country 14.4.1.1. U.S. 14.4.1.2. Canada 14.4.2. By Plant Type 14.4.3. By Protein Type 14.4.4. By Platform Type 14.4.5. By Application 14.4.6. By End User 14.5. Market Attractiveness Analysis 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 15. Latin America Market Analysis 2014-2021 and Forecast 2022-2029 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021 15.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029 15.4.1. By Country 15.4.1.1. Brazil 15.4.1.2. Mexico 15.4.1.3. Argentina 15.4.1.4. Rest of Latin America 15.4.2. By Plant Type 15.4.3. By Protein Type 15.4.4. By Platform Type 15.4.5. By Application 15.4.6. By End User 15.5. Market Attractiveness Analysis 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 16. Europe Market Analysis 2014-2021 and Forecast 2022-2029 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021 16.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029 16.4.1. By Country 16.4.1.1. Germany 16.4.1.2. Italy 16.4.1.3. France 16.4.1.4. U.K. 16.4.1.5. Spain 16.4.1.6. BENELUX 16.4.1.7. Russia 16.4.1.8. Rest of Europe 16.4.2. By Plant Type 16.4.3. By Protein Type 16.4.4. By Platform Type 16.4.5. By Application 16.4.6. By End User 16.5. Market Attractiveness Analysis 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 2014-2021 and Forecast 2022-2029 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021 17.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029 17.4.1. By Country 17.4.1.1. India 17.4.1.2. Thailand 17.4.1.3. Indonesia 17.4.1.4. Malaysia 17.4.1.5. Rest of South Asia 17.4.2. By Plant Type 17.4.3. By Protein Type 17.4.4. By Platform Type 17.4.5. By Application 17.4.6. By End User 17.5. Market Attractiveness Analysis 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 18. East Asia Market Analysis 2014-2021 and Forecast 2022-2029 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021 18.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029 18.4.1. By Country 18.4.1.1. China 18.4.1.2. Japan 18.4.1.3. South Korea 18.4.2. By Plant Type 18.4.3. By Protein Type 18.4.4. By Platform Type 18.4.5. By Application 18.4.6. By End User 18.5. Market Attractiveness Analysis 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 19. Oceania Market Analysis 2014-2021 and Forecast 2022-2029 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021 19.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029 19.4.1. By Country 19.4.1.1. Australia 19.4.1.2. New Zealand 19.4.2. By Plant Type 19.4.3. By Protein Type 19.4.4. By Platform Type 19.4.5. By Application 19.4.6. By End User 19.5. Market Attractiveness Analysis 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Market Analysis 2014-2021 and Forecast 2022-2029 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021 20.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029 20.4.1. By Country 20.4.1.1. GCC Countries 20.4.1.2. South Africa 20.4.1.3. Rest of Middle East and Africa 20.4.2. By Plant Type 20.4.3. By Protein Type 20.4.4. By Platform Type 20.4.5. By Application 20.4.6. By End User 20.5. Market Attractiveness Analysis 20.6. Key Market Participants - Intensity Mapping 20.7. Drivers and Restraints - Impact Analysis 21. Emerging Countries Market Analysis 2014-2021 and Forecast 2022-2029 21.1. Introduction 21.1.1. Market Value Proportion Analysis, By Key Countries 21.1.2. Global Vs. Country Growth Comparison 21.2. China Market Analysis 21.2.1. Introduction 21.2.2. Pricing Analysis 21.2.3. PEST Analysis 21.2.4. Market Value Proportion Analysis by Market Taxonomy 21.2.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 21.2.5.1. By Plant Type 21.2.5.2. By Protein Type 21.2.5.3. By Platform Type 21.2.5.4. By Application 21.2.5.5. By End User 21.2.6. China Market - Competition Landscape 21.3. India Market Analysis 21.3.1. Introduction 21.3.2. Pricing Analysis 21.3.3. PEST Analysis 21.3.4. Market Value Proportion Analysis by Market Taxonomy 21.3.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 21.3.5.1. By Plant Type 21.3.5.2. By Protein Type 21.3.5.3. By Platform Type 21.3.5.4. By Application 21.3.5.5. By End User 21.3.6. India Market - Competition Landscape 21.4. Brazil Market Analysis 21.4.1. Introduction 21.4.2. Pricing Analysis 21.4.3. PEST Analysis 21.4.4. Market Value Proportion Analysis by Market Taxonomy 21.4.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 21.4.5.1. By Plant Type 21.4.5.2. By Protein Type 21.4.5.3. By Platform Type 21.4.5.4. By Application 21.4.5.5. By End User 21.4.6. Brazil Market - Competition Landscape 22. Market Structure Analysis 22.1. Market Analysis by Tier of Companies (Tissue Diagnostics ) 22.2. Market Concentration By Tope Players, 2021 22.3. Market Value Share Analysis of Top 10 Players 22.4. Market Presence Analysis 22.4.1. By Regional Market Footprint of Players 22.4.2. Product Footprint by Players 22.4.3. Channel Footprint by Players 23. Competition Analysis 23.1. Competition Dashboard 23.2. Pricing Analysis by Competition 23.3. Competition Benchmarking 23.4. Competition Deep pe 23.4.1. Medicago Inc. 23.4.1.1. Company Overview 23.4.1.2. Product Portfolio & Application 23.4.1.3. Product & Sales Footprint 23.4.1.4. SWOT Analysis 23.4.1.5. Strategy Overview 23.4.1.5.1. Marketing Strategy 23.4.1.5.2. Product Strategy 23.4.1.5.3. Channel Strategy 23.4.1.6. Analyst Commentary. 23.4.2. Planet Biotechnology Inc. 23.4.2.1. Company Overview 23.4.2.2. Product Portfolio & Application 23.4.2.3. Product & Sales Footprint 23.4.2.4. SWOT Analysis 23.4.2.5. Strategy Overview 23.4.2.5.1. Marketing Strategy 23.4.2.5.2. Product Strategy 23.4.2.5.3. Channel Strategy 23.4.2.6. Analyst Commentary. 23.4.3. Kentucky Bioprocessing, LLC 23.4.3.1. Company Overview 23.4.3.2. Product Portfolio & Application 23.4.3.3. Product & Sales Footprint 23.4.3.4. SWOT Analysis 23.4.3.5. Strategy Overview 23.4.3.5.1. Marketing Strategy 23.4.3.5.2. Product Strategy 23.4.3.5.3. Channel Strategy 23.4.3.6. Analyst Commentary. 23.4.4. Ventria Bioscience 23.4.4.1. Company Overview 23.4.4.2. Product Portfolio & Application 23.4.4.3. Product & Sales Footprint 23.4.4.4. SWOT Analysis 23.4.4.5. Strategy Overview 23.4.4.5.1. Marketing Strategy 23.4.4.5.2. Product Strategy 23.4.4.5.3. Channel Strategy 23.4.4.6. Analyst Commentary. 23.4.5. Icon Genetics 23.4.5.1. Company Overview 23.4.5.2. Product Portfolio & Application 23.4.5.3. Product & Sales Footprint 23.4.5.4. SWOT Analysis 23.4.5.5. Strategy Overview 23.4.5.5.1. Marketing Strategy 23.4.5.5.2. Product Strategy 23.4.5.5.3. Channel Strategy 23.4.5.6. Analyst Commentary. 23.4.6. PromoCell GmbH 23.4.6.1. Company Overview 23.4.6.2. Product Portfolio & Application 23.4.6.3. Product & Sales Footprint 23.4.6.4. SWOT Analysis 23.4.6.5. Strategy Overview 23.4.6.5.1. Marketing Strategy 23.4.6.5.2. Product Strategy 23.4.6.5.3. Channel Strategy 23.4.6.6. Analyst Commentary. 23.4.7. Agrenvec 23.4.7.1. Company Overview 23.4.7.2. Product Portfolio & Application 23.4.7.3. Product & Sales Footprint 23.4.7.4. SWOT Analysis 23.4.7.5. Strategy Overview 23.4.7.5.1. Marketing Strategy 23.4.7.5.2. Product Strategy 23.4.7.5.3. Channel Strategy 23.4.7.6. Analyst Commentary. 23.4.8. Axol Bioscience Ltd 23.4.8.1. Company Overview 23.4.8.2. Product Portfolio & Application 23.4.8.3. Product & Sales Footprint 23.4.8.4. SWOT Analysis 23.4.8.5. Strategy Overview 23.4.8.5.1. Marketing Strategy 23.4.8.5.2. Product Strategy 23.4.8.5.3. Channel Strategy 23.4.8.6. Analyst Commentary. 24. Assumptions & Acronyms Used 25. Research Methodology
Explore Healthcare Insights
View Reports
Plant Derived Proteins Market
